ALS Center – Neurology Departement

CHU Dupuytren

The ALS Center at CHU Dupuytren organizes high quality care for ALS patients, education for healthcare professionals and engages in clinical research activities.

Limoges_logo
CHU Dupuytren

Patients diagnosed with ALS receive a multidisciplinary evaluation every 3 months. In addition, we provide medical, social and home support. To share our expertise regarding care for ALS patients, we provide training sessions for medical and paramedical staff, and organise a symposium with other French ALS Centers. Our research interests include epidemiology, cognition and nutrition. To this extent, we establish internal and multicenter research protocols and collaborate with the pharmaceutical industry in therapeutic research.

 

Contact
Location
2 Avenue Martin Luther King, Limoges, France

Our Specialists

Philippe Couratier

Professor of Neurology

Professor Philippe Couratier is Neurologist in the University Hospital of Limoges. After […]

Philippe Couratier
Current trials
Active
Phase ii

RT001 in Amyotrophic Lateral Sclerosis

Industry trial
In this phase 2 trial, we will study the safety and efficacy of the compound RT001 in people living with ALS. This clinical trial is sponsored by Retrotope Inc.
Read more
Active
Phase iii

ALXN1210-ALS-308 trial

Industry trial
This phase 3 trial aims to study the safety and efficacy of the drug ‘ravulizumab’ in people living with ALS. To register for this study, you should contact your local ALS centre or treating physician.
Read more
Active
Phase iii

VALOR study

Industry trial
Biogen is conducting a clinical trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS) with a SOD1 gene mutation.
Read more
Recruiting
Phase iii

TUDCA-ALS

Investigator initiated trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.
Read more